Condition (MeSH)
Pregnancy Complications, Neoplastic
ClinicalTrials.gov lists 75 trials for Pregnancy Complications, Neoplastic or a narrower condition beneath it. Gynecologic Oncology Group has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
When did Pregnancy Complications, Neoplastic trials start? (28)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 7 |
| 2023 | 3 |
| 2022 | 2 |
| 2021 | 5 |
| 2020 | 3 |
| 2019 | 4 |
| 2018 | 2 |
| 2017 | 2 |
Showing 10 of 28 earlier years.
No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 10 trials still running at the 2026-10-09 snapshot; registered median of 35 months across 35 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pregnancy Complications, Neoplastic trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 5 |
| Phase 1/2 | 2 |
| Phase 2 | 24 |
| Phase 2/3 | 4 |
| Phase 3 | 10 |
| Phase 4 | 1 |
| Not applicable | 8 |
| Observational | 21 |
How many Pregnancy Complications, Neoplastic trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 13 |
| Active, not recruiting | 5 |
| Completed | 32 |
| Terminated | 5 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pregnancy Complications, Neoplastic trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Gynecologic Oncology Group | 6 |
| Children's Oncology Group | 3 |
| Tracon Pharmaceuticals Inc. | 2 |
| AstraZeneca | 1 |
Which drugs are being tested for Pregnancy Complications, Neoplastic? (6)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Dactinomycin | 7 |
| NIVOLUMAB | 2 |
| G-CSF | 2 |
| TORIPALIMAB | 2 |
| Cytoxan | 2 |
Showing 5 of 6 drugs.
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| HD- Methotrexate (MTX) | 7 |
| or carboplatin | 4 |
| Etoposid | 4 |
| Ifosfamid | 3 |
| AG chemotherapy | 2 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pregnancy Complications, Neoplastic trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Febrile Neutropenia | 6 | 1 |
| Infection | 2 | 1 |
| Vomiting | 2 | 1 |
| Appendicitis | 1 | 1 |
| Diarrhea | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Pregnancy Complications, Neoplastic? (158)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2025 | Yes |
| Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. | JAMA | 2024 | Yes |
| Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer. | The New England journal of medicine | 2024 | Yes |
| A prospective registry-based cohort study of the diagnosis and management of acute leukaemia in pregnancy: Study protocol. | PloS one | 2022 | Yes |
| Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. | Cancer | 2021 | Yes |
Showing 5 of 158 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.